The predominance of Notch, PI3K/AKT, and Wnt/β-catenin pathways suggest their critical roles in GSC maintenance and glioma progression, guiding therapeutic strategies aimed at these pathways. The gene discussed is AKT1; the disease is central nervous system cancer.